Pharmacy Benefit Manager

An intermediary company that administers prescription drug programs for commercial health plans, employers, and government programs.

A Pharmacy Benefit Manager (PBM) is a third-party administrator of prescription drug programs for commercial health plans, self-insured employers, labor unions, and government programs. Operating as intermediaries in the healthcare supply chain, PBMs sit between drug manufacturers, pharmacies, health insurance companies, and patients. They are responsible for negotiating rebates with drug makers, establishing networks of retail pharmacies, processing prescription claims, and developing formularies, which are the lists of approved drugs covered by a health plan. Investors analyze PBMs because of their massive scale and influence over the pricing and distribution of pharmaceuticals. PBMs generate revenue through administrative fees, spread pricing (retaining the difference between what they charge the plan sponsor and what they pay the pharmacy), and by keeping a portion of the rebates negotiated with drug manufacturers. Consequently, their business models heavily impact the profit margins of health insurers, retail pharmacies, and drug developers. When evaluating companies in this space, investors look closely at rebate pass-through rates and regulatory risks. High-volume PBMs historically enjoyed significant pricing power, but they face intense scrutiny from policymakers regarding transparency and whether they pass negotiated savings on to consumers. A shift toward models that pass 100% of rebates back to the plan sponsor can compress a PBM's profit margins, while changes in formulary placement can instantly shift market share between competing drug manufacturers.

A PBM negotiates a rebate with a drug manufacturer for a brand-name medication that has a list price of $100. The manufacturer agrees to a $30 rebate. Under a partial pass-through contract, the PBM passes $25 of that rebate back to the health insurance plan and retains $5 as its own revenue. If the PBM processes 1,000,000 prescriptions of this drug annually, its retained rebate revenue from this single drug is 1,000,000 multiplied by $5, which equals $5,000,000.